| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| BMS-986263 | BMS-986263; ND-L02-s0201 | Phase 2 Clinical | Hokkaido University, Nitto Denko, Sapporo Medical University | Fibrosis; Hepatic Insufficiency; Idiopathic Pulmonary Fibrosis; Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |
| INV-001 | INV-001 | Phase 2 Clinical | Innovo Therapeutics Inc | Cicatrix | Details |